Spartacus Acquisition (NN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Legend Biotech Corp (LEGN) reports significant sales growth and outlines future strategies amid ongoing challenges.
Humacyte Inc (HUMA) reports increased Symvess sales and strategic advancements, despite ongoing financial pressures and a net loss reduction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback